SANGAMO BIOSCIENCES INC
10-Q, EX-27.1, 2000-08-11
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: SANGAMO BIOSCIENCES INC, 10-Q, 2000-08-11
Next: WHITEWING LABS INC, 10QSB, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM BALANCE
SHEET AND INCOME STATEMENTS DATED 06/30/00 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             APR-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                      39,586,000
<SECURITIES>                                27,494,000
<RECEIVABLES>                                  362,000
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            56,283,000
<PP&E>                                       1,776,000
<DEPRECIATION>                                 398,000
<TOTAL-ASSETS>                              69,793,000
<CURRENT-LIABILITIES>                        1,077,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                    88,311,000
<OTHER-SE>                                (19,594,000)
<TOTAL-LIABILITY-AND-EQUITY>                69,793,000
<SALES>                                              0
<TOTAL-REVENUES>                               747,000
<CGS>                                                0
<TOTAL-COSTS>                                3,458,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             987,000
<INCOME-PRETAX>                            (1,725,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,725,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,725,000)
<EPS-BASIC>                                   (0.08)
<EPS-DILUTED>                                   (0.08)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission